These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 12242667
1. The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells. Baldi A, De Luca A, Morini M, Battista T, Felsani A, Baldi F, Catricalà C, Amantea A, Noonan DM, Albini A, Natali PG, Lombardi D, Paggi MG. Oncogene; 2002 Sep 26; 21(43):6684-8. PubMed ID: 12242667 [Abstract] [Full Text] [Related]
2. Ferritin contributes to melanoma progression by modulating cell growth and sensitivity to oxidative stress. Baldi A, Lombardi D, Russo P, Palescandolo E, De Luca A, Santini D, Baldi F, Rossiello L, Dell'Anna ML, Mastrofrancesco A, Maresca V, Flori E, Natali PG, Picardo M, Paggi MG. Clin Cancer Res; 2005 May 01; 11(9):3175-83. PubMed ID: 15867210 [Abstract] [Full Text] [Related]
3. Serine proteases HTRA1 and HTRA3 are down-regulated with increasing grades of human endometrial cancer. Bowden MA, Di Nezza-Cossens LA, Jobling T, Salamonsen LA, Nie G. Gynecol Oncol; 2006 Oct 01; 103(1):253-60. PubMed ID: 16650464 [Abstract] [Full Text] [Related]
4. Analysis of HtrA1 serine protease expression in human lung cancer. Esposito V, Campioni M, De Luca A, Spugnini EP, Baldi F, Cassandro R, Mancini A, Vincenzi B, Groeger A, Caputi M, Baldi A. Anticancer Res; 2006 Oct 01; 26(5A):3455-9. PubMed ID: 17094466 [Abstract] [Full Text] [Related]
5. Identification of the human PHLDA1/TDAG51 gene: down-regulation in metastatic melanoma contributes to apoptosis resistance and growth deregulation. Neef R, Kuske MA, Pröls E, Johnson JP. Cancer Res; 2002 Oct 15; 62(20):5920-9. PubMed ID: 12384558 [Abstract] [Full Text] [Related]
6. Expression patterns of two serine protease HtrA1 forms in human placentas complicated by preeclampsia with and without intrauterine growth restriction. Lorenzi T, Marzioni D, Giannubilo S, Quaranta A, Crescimanno C, De Luca A, Baldi A, Todros T, Tranquilli AL, Castellucci M. Placenta; 2009 Jan 15; 30(1):35-40. PubMed ID: 19056122 [Abstract] [Full Text] [Related]
7. A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer. Chien J, Staub J, Hu SI, Erickson-Johnson MR, Couch FJ, Smith DI, Crowl RM, Kaufmann SH, Shridhar V. Oncogene; 2004 Feb 26; 23(8):1636-44. PubMed ID: 14716297 [Abstract] [Full Text] [Related]
8. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases. Schietroma C, Cianfarani F, Lacal PM, Odorisio T, Orecchia A, Kanitakis J, D'Atri S, Failla CM, Zambruno G. Cancer; 2003 Aug 15; 98(4):789-97. PubMed ID: 12910524 [Abstract] [Full Text] [Related]
11. Cyclin-dependent kinase 2 expression in human melanomas and benign melanocytic skin lesions. Kuźbicki L, Aładowicz E, Chwirot BW. Melanoma Res; 2006 Oct 15; 16(5):435-44. PubMed ID: 17013093 [Abstract] [Full Text] [Related]
12. Distinct expression and localization of serine protease HtrA1 in human endometrium and first-trimester placenta. Nie G, Hale K, Li Y, Manuelpillai U, Wallace EM, Salamonsen LA. Dev Dyn; 2006 Dec 15; 235(12):3448-55. PubMed ID: 17072861 [Abstract] [Full Text] [Related]
13. HtrA1 is a novel mast cell serine protease of mice and men. Gilicze A, Kohalmi B, Pocza P, Keszei M, Jaeger J, Gorbe E, Papp Z, Toth S, Falus A, Wiener Z. Mol Immunol; 2007 Apr 15; 44(11):2961-8. PubMed ID: 17292962 [Abstract] [Full Text] [Related]
14. Analysis of APAF-1 expression in human cutaneous melanoma progression. Baldi A, Santini D, Russo P, Catricalà C, Amantea A, Picardo M, Tatangelo F, Botti G, Dragonetti E, Murace R, Tonini G, Natali PG, Baldi F, Paggi MG. Exp Dermatol; 2004 Feb 15; 13(2):93-7. PubMed ID: 15009102 [Abstract] [Full Text] [Related]
15. Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Jaeger J, Koczan D, Thiesen HJ, Ibrahim SM, Gross G, Spang R, Kunz M. Clin Cancer Res; 2007 Feb 01; 13(3):806-15. PubMed ID: 17289871 [Abstract] [Full Text] [Related]
16. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Hazarika P, McCarty MF, Prieto VG, George S, Babu D, Koul D, Bar-Eli M, Duvic M. Cancer Res; 2004 Oct 15; 64(20):7361-9. PubMed ID: 15492257 [Abstract] [Full Text] [Related]
17. RaLP, a new member of the Src homology and collagen family, regulates cell migration and tumor growth of metastatic melanomas. Fagiani E, Giardina G, Luzi L, Cesaroni M, Quarto M, Capra M, Germano G, Bono M, Capillo M, Pelicci P, Lanfrancone L. Cancer Res; 2007 Apr 01; 67(7):3064-73. PubMed ID: 17409413 [Abstract] [Full Text] [Related]
18. Elevated expression of serine protease HtrA1 in preeclampsia and its role in trophoblast cell migration and invasion. Ajayi F, Kongoasa N, Gaffey T, Asmann YW, Watson WJ, Baldi A, Lala P, Shridhar V, Brost B, Chien J. Am J Obstet Gynecol; 2008 Nov 01; 199(5):557.e1-10. PubMed ID: 18667191 [Abstract] [Full Text] [Related]
19. HtrA1 serine protease inhibits signaling mediated by Tgfbeta family proteins. Oka C, Tsujimoto R, Kajikawa M, Koshiba-Takeuchi K, Ina J, Yano M, Tsuchiya A, Ueta Y, Soma A, Kanda H, Matsumoto M, Kawaichi M. Development; 2004 Mar 01; 131(5):1041-53. PubMed ID: 14973287 [Abstract] [Full Text] [Related]
20. Expression and regulation of HTRA1 during chick and early mouse development. Ferrer-Vaquer A, Maurey P, Werzowa J, Firnberg N, Leibbrandt A, Neubüser A. Dev Dyn; 2008 Jul 01; 237(7):1893-900. PubMed ID: 18570253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]